Staccato Loxapine in Agitated Patients With Schizophrenia

Clinical trial NCT00628589 · COMPLETED

Trial details

NCT number: NCT00628589
Sponsor: Alexza Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Patients With Schizophrenia and Acute Agitation

Start date: 2008-02-01
Primary completion: 2008-05-01
Enrollment: 344

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.